| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Director | Common Stock | 6,250 | $159,750 | $25.56 | 11 Jun 2025 | Direct |
| Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23,746 | 09 Jun 2025 | Direct | ||
| Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 22,200 | 29 May 2025 | Direct | ||
| Septerna, Inc. | Director | Stock Option (Right to Buy) | 16,623 | 17 Jun 2025 | Direct | ||
| Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 11,667 | 11 Jun 2025 | Direct | ||
| DICE Therapeutics, Inc. | Director | Stock Option (right to buy Common Stock) | 0 | 09 Aug 2023 | Direct |